# Prostate Cancer Stereotactic Radiotherapy

> **NCT02319239** · NA · COMPLETED · sponsor: **Tampere University Hospital** · enrollment: 80 (actual)

## Conditions studied

- Prostate Neoplasms
- Toxicity Due to Radiotherapy

## Interventions

- **RADIATION:** Fractionation
- **RADIATION:** hypofractionated
- **RADIATION:** stereotactic fractionation

## Key facts

- **NCT ID:** NCT02319239
- **Lead sponsor:** Tampere University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2020-10
- **Final completion:** 2020-10
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02319239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02319239, "Prostate Cancer Stereotactic Radiotherapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02319239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*